LIST OF SUBMITTED E-POSTERS (FINAL)
THIS PAGE HAS BEEN UPDATED ON: 1 AUGUST 2021
- NO SESSION, ABSTRACT, OR TITLE CHANGES ARE ACCEPTED ANYMORE AFTER 15 JULY 2021.
- ONLY SPEAKER SUBSTITUTIONS ARE ALLOWED.
- THE BELOW LIST HAS BEEN ADDED TO THE WEBSITE AND IN THE WC11 MAGAZINE AND WILL NOT BE CHANGED ANYMORE AFTER 1 AUGUST 2021.
- CHANGES WILL ONLY BE DONE DIRECTLY AND EXCLUSIVELY IN THE WC11 VIRTUAL EVENT PLATFORM.
POSTER SESSIONS
The program of the 11th World Congress on Alternatives and Animal Use in the Life Sciences (WC11) will be virtual due to continued COVID-19 imposed restrictions, and will be spread over a two-week period, from 23 August - 2 September 2021.
As the platform will open on 10 August 2021, all posters will be available for poster viewings from 10 August 2021 until 2 September 2021.
The congress has two dedicated poster sessions:
- Friday 27 August 2021: 6 PM - 7.30 PM
- Tuesday 31 August 2021: 5.15 PM - 6.15 PM
During these two poster sessions, you can enter the virtual room of the poster presenter to ask questions or discuss the poster. Outside the poster session hours, you can visit the poster profile and ask questions to the presenter via chat.
Theme 1: Safety
- P5 IN VITRO APPROACH FOR ASSESSING RESPIRATORY TOXICITY IN HUMAN LUNG CELLS
Amy Clippinger, PETA Science Consortium International (ABSTRACT ID: 43) - P20 USG & RJ LEE IN-VITRO STUDY ON THE BIOPERSISTENCE OF RESPIRABLE MINERAL FIBERS WITH EXISTING AND REFINED TEST METHODS
Keith Rickabaugh, RJ Lee Group (ABSTRACT ID: 116) - P22 WORKSHOP ON THE IMPLEMENTATION OF NEXT GENERATION RISK ASSESSMENT (NGRA) FOR SYSTEMIC TOXICITY
Mabel Cotter, Unilever (ABSTRACT ID: 119) - P25 THE EX VIVO EYE IRRITATION TEST (EVEIT) SYSTEM IN THE DISTINCTION BETWEEN SLIGHT AND SEVERE CORROSIVES
Norbert Schrage, Aachen Centre of Technology Transfer in Ophthalmology, (ACTO e. V.), Aachen, Germany (ABSTRACT ID: 124) - P28 RETHINKING CARCINOGENICITY ASSESSMENT FOR AGROCHEMICALS
Gina Hilton, PETA Science Consortium International e.V. (ABSTRACT ID: 129) - P29 DIFFERENTIAL INFLUENCE OF STREPTOCOCCUS MITIS ON HOST RESPONSE TO METALS IN RECONSTRUCTED HUMAN SKIN AND ORAL MUCOSA
Sue Gibbs, Amsterdam UMC & ACTA (ABSTRACT ID: 130) - P50 A NOVEL STRATEGY COMBINING ITS AND READ-ACROSS TO PREDICT THE SKIN SENSITIZATION POTENCY OF CHEMICALS
Kanako Nakayama, Kao Corporation (ABSTRACT ID: 175) - P52 A VALIDATION STUDY OF THE IATA-BASED READ-ACROSS IN NEPHROTOXICITY OF AMINOPHENOLS
KEITA YOSHIHARA, Kao Corporation (ABSTRACT ID: 177) - P60 A NOVEL MICROFLUIDIC PLATFORM FOR PULMONARY NANOPARTICLE EXPOSURE
Flora Marta Kiss, Technical University of Berlin - TissUse GmbH (ABSTRACT ID: 192) - P61 NEXT GENERATION RISK ASSESSMENT OF HUMAN EXPOSURE TO ANTI-ANDROGENS USING NEWLY DEFINED COMPARATOR COMPOUND VALUES
Tessa van Tongeren, Wageningen University and Reserach (ABSTRACT ID: 193) - P65 RAINBOWFLOW CHIP AN IMPEDANCE-BASED BIOSENSOR FOR CHEMICAL HAZARD ASSESSMENT WITH FISH CELL LINES AT ITS CORE
Jenny Maner, Eawag (ABSTRACT ID: 200) - P66 VERIFICATION OF THE APPLICABLE DOMAIN OF REACTIVE OXYGEN SPECIES (ROS) ASSAY FOR DEVELOPING PHOTOSAFETY COSMETIC INGREDIENTS
TAKUMI NUKAGA, SHISEIDO (ABSTRACT ID: 201) - P78 SKINETHIC™ HCE TIME-TO-TOXICITY THE FIRST INDIVIDUAL METHOD FORMALLY CONSIDERED BY THE OECD FOR DISCRIMINATING ON ITS OWN THE THREE UN GHS OCULAR HAZARD CATEGORIES
Nathalie Alépée, L'Oreal (ABSTRACT ID: 219) - P80 COSMETICS EUROPE EYE PROGRAM APPLICATION OF TWO DEFINED APPROACHES FOR OCULAR TOXICITY PREDICTIONS BASED ON IN VITRO BOTTOM-UP APPROACH ON 4 CASE STUDIES
Nathalie Alépée, L'Oreal (ABSTRACT ID: 221) - P81 THE BOTANICAL SAFETY CONSORTIUM’S STRATEGY FOR DEVELOPING A ROBUST FRAMEWORK OF GENOTOXICITY ASSAYS FOR SAFETY ASSESSMENT OF BOTANICAL SUBSTANCES
Kristine Witt, NIEHS/DNTP (ABSTRACT ID: 223) - P91 NEW INSIGHTS IN READ ACROSS USING NEW APPROACH METHODS
Catherine Mahony, Procter & Gamble Technical Centres Ltd, Reading, UK (ABSTRACT ID: 247) - P92 ASSESSING THE REPRODUCIBILITY OF PUBLISHED PHYSIOLOGICALLY-BASED KINETIC MODELS
Courtney Thompson, Liverpool John Moores University (ABSTRACT ID: 248) - P95 USE OF 3D HUMAN LIVER MICROTISSUES TO ASSESS HEPATOTOXICITY OF BIOLOGICS
Annie Delaunois, UCB Biopharma SRL (ABSTRACT ID: 253) - P96 DISRUPTION OF CELLULAR MIGRATION/ADHESION AS COMMON KEY EVENT IN DRUG-INDUCED LIVER INJURY; OPTIONS FOR NEW IN VITRO TESTING STRATEGIES.
Raymond Pieters, Hogeschool Utrecht and Utrecht University (ABSTRACT ID: 254) - P97 USE OF A DYNAMIC SKIN AND LIVER CO-CULTURE MODEL TO INVESTIGATE THE EFFECT OF APPLICATION ROUTE ON THE METABOLISM OF THE HAIR DYE, 4-AMINO-2-HYDROXYTOLUENE
Thi Phuong Tao, TissUse GmbH (ABSTRACT ID: 256) - P98 UPDATED DERMAL SENSITISATION THRESHOLDS DERIVED USING AN IN SILICO EXPERT SYSTEM AND AN EXPANDED LOCAL LYMPH NODE ASSAY DATASET
Martyn Chilton, Lhasa Limited (ABSTRACT ID: 261) - P99 NEXT GENERATION RISK ASSESSMENT APPROACH FOR INHALATION EXPOSURES POLYMER CASE STUDIES
Maria Baltazar, Unilever (ABSTRACT ID: 263) - P100 IDENTIFYING AND CHARACTERIZING STRESS PATHWAYS OF CONCERN FOR CONSUMER SAFETY IN NEXT GENERATION RISK ASSESSMENT
Maria Baltazar, Unilever (ABSTRACT ID: 264) - P102 PROPOSAL OF A NEW APPLICABILITY DOMAIN OF VITRIGEL-EIT (EYE IRRITANCY TEST) METHOD UTILIZING THE PH LEVEL AND LIGHT ABSORBANCE OF TEST CHEMICAL PREPARATIONS
Hiroyuki Yamaguchi, National Agriculture and Food Research Organization, Institute of Agrobiological Sciences, Tsukuba, Japan, Kanto Chemical Co., Inc. (ABSTRACT ID: 269) - P106 A NEXT GENERATION RISK ASSESSMENT CASE STUDY FOR COUMARIN IN HYPOTHETICAL COSMETIC PRODUCTS
Sophie Cable , Unilever (ABSTRACT ID: 273) - P115 PRIMARY OR IPSC-DERIVED CELL-BASED CYTOTOXICITY ASSAYS TO ASSESS POTENTIAL SAFETY RISKS OF ENGINEERED T CELL THERAPIES IN VITRO
Marco Guadagnoli, Charles River Laboratories (ABSTRACT ID: 295) - P116 GENERATION OF NOVEL, INTEGRATED AND INTERNATIONALLY HARMONISED APPROACHES FOR TESTING METABOLISM DISRUPTING COMPOUNDS (GOLIATH)
Sebastian Hoffmann, seh consulting + services (ABSTRACT ID: 296) - P120 ESTABLISHMENT OF A RISK ASSESSMENT METHOD AND THRESHOLD OF TOXICOLOGICAL CONCERN (TTC) CONCEPT FOR SKIN SENSITIZATION BY NON-ANIMAL APPROACHES
Takao Ashikaga, National Institute of Health Sciences, Japan (ABSTRACT ID: 305) - P124 NEW APPROACH FOR SYSTEMIC TOXICITY HAZARD ASSESSMENT BASED ON ALTERNATIVE METHODS TO ANIMAL TESTING IN SUPPORT OF SAFETY DECISION-MAKING
Emilie BARBEAU, L'Oréal (ABSTRACT ID: 311) - P128 DEIODINASE 1 IN HUMAN LIVER MICROSOMES IS INHIBITED BY ORGANIC AND INORGANIC GOLD COMPOUNDS AND GOLD NANOPARTICLES
Andreas Weber, BASF SE (ABSTRACT ID: 316) - P129 THE THRESHOLD OF TOXICOLOGICAL CONCERN (TTC) IS A PRAGMATIC RISK ASSESSMENT TOOL FOR THE SAFETY ASSESSMENT OF COSMETIC INGREDIENTS WITH LOW CONSUMER EXPOSURE
Mustafa Varçin, Cosmetics Europe (ABSTRACT ID: 317) - P130 A NEW GROWTH-FACTOR FREE HUMAN CELL BASED IN VITRO ANGIOGENESIS ASSAY FOR TESTING ANGIOGENESIS INHIBITORS
Barbara Birk, BASF SE (ABSTRACT ID: 318) - P132 MINING RETINOIC ACID PATHWAY RELATED BIOMARKERS OF VERTEBRATE DEVELOPMENTAL TOXICITY IN THE ZEBRAFISH EMBRYO MODEL.
Laura Samrani, RIVM (ABSTRACT ID: 322) - P135 OECD APPROVAL IS NOT THE END OF THE STORY – ARE EXISTING TEST METHODS (OECD 442C, D AND E) APPLICABLE TO NANOMATERIALS?
Barbara Birk, BASF SE (ABSTRACT ID: 326) - P136 SENSITIZATION POTENTIAL OF MEDICAL DEVICES DETECTED BY METHODS IN VITRO AND IN VIVO
Lada Svobodova, National Institute of Public Health (ABSTRACT ID: 328) - P140 THE GARDPOTENCY ASSAY FOR POTENCY-ASSOCIATED SUBCLASSIFICATION OF CHEMICAL SKIN SENSITIZERS – RATIONALE, METHOD DEVELOPMENT AND RING TRIAL RESULTS OF PREDICTIVE PERFORMANCE AND REPRODUCIBILITY.
Henrik Johansson, SenzaGen AB (ABSTRACT ID: 334) - P142 TOXICITY TESTING IN AN IN VITRO MODEL FOR ANTI-CARCINOGENESIS DEMONSTRATES THE IMPROVED PREVENTIVE EFFECTS OF COMBINATIONS OF BIOACTIVE COMPOUNDS AS COMPARED TO SINGLE COMPOUNDS
Simone van Breda, Maastricht University (ABSTRACT ID: 338) - P146 RELIABLE AND TRULY ANIMAL-FREE SKIN SENSITIZATION TESTING – ADAPTION OF THE IN VITRO GARDSKIN ASSAY TO ANIMAL FREE CONDITIONS
Andy Forreryd, SenzaGen AB (ABSTRACT ID: 346) - P147 HAZARD ASSESSMENT OF PHOTOALLERGENS USING GARD™SKIN
Andy Forreryd, SenzaGen AB (ABSTRACT ID: 348) - P148 PRACTICAL APPLICATION OF IN SILICO APPROACHES IN NEXT GENERATION RISK ASSESSMENT FOR CONSUMER PRODUCTS
Steve Gutsell, Unilever (ABSTRACT ID: 349) - P149 FRAMEWORK FOR PHYSIOLOGICALLY-BASED KINETICS (PBK) MODELLING IN THE NEXT GENERATION RISK ASSESSMENT (NGRA) OF CONSUMER GOODS.
Tom Moxon, Unilever (ABSTRACT ID: 352) - P150 AN IN VITRO MICROFLUIDIC MODEL OF THE HUMAN CARDIOVASCULAR SYSTEM FOR USE IN SCREENING APPLICATIONS – ASSESSMENT OF MONOCYTE-TO-ENDOTHELIAL CELL ADHESION AND CYTOKINE ANALYSIS
Gina Smith, Labcorp Drug Development (ABSTRACT ID: 357) - P151 NEXT GENERATION RISK ASSESSMENT FOR SKIN ALLERGY 0.1% COUMARIN IN FACE CREAM AB INITIO CASE STUDY
Georgia Reynolds, SEAC, Unilever (ABSTRACT ID: 358) - P156 DEVELOPMENT OF MECHANISM-BASED HEMATOTOXICITY CATEGORIES FOR READ-ACROSS ASSESSMENT USING AN INTEGRATED TOXICITY DATABASE OF CHEMICAL SUBSTANCES
Takashi Yamada, Division of Risk Assessment, Center for Biological Safety Research, National Institute of Health Sciences (ABSTRACT ID: 370) - P157 SUCCESSFUL IMPLEMENTATION OF U-SENS™ ASSAY FOR SKIN SENSITIZATION TESTING (OECD TG442E) IN CHINA
Lizao Chen, L'Oréal Research & Innovation China (ABSTRACT ID: 372) - P158 A READY-TO-USE INTEGRATED IN VITRO SKIN CORROSION AND IRRITATION TESTING STRATEGY USING EPISKIN™ MODEL IN CHINA
yanfeng liu, L'OREAL (ABSTRACT ID: 374) - P159 MULTI-CENTER VALIDATION OF EPISKIN™ MICRONUCLEUS ASSAY A 3D APPROACH FOR THE ASSESSMENT OF GENOTOXICITY POTENTIAL
Lizao Chen, L'Oréal Research & Innovation China (ABSTRACT ID: 375) - P163 DEVELOPMENT OF A 3D SKIN COMET ASSAY BUILDING UP THE FOUNDATION FOR HIGHER TIER IN VITRO TESTING BATTERY OF GENOTOXICITY
QIN QIN, Loreal research & innovation, China (ABSTRACT ID: 380) - P164 FULL REPLACEMENT OF REGULATORY SKIN SENSITIZATION TESTING WITH VALIDATED IN VITRO TESTS INTEGRATING THE KINETIC PEPTIDE REACTIVITY ASSAY INTO THE TEST BATTERY
Andreas Natsch, Givaudan Schweiz AG (ABSTRACT ID: 382) - P174 IN VITRO EVALUATION OF GENOTOXICITY AND IRRITATION POTENTIAL OF EYE DROPS CONTAINING AQUEOUS PLANT EXTRACTS
Ilona Zilkowski, WALA Heilmittel GmbH (ABSTRACT ID: 395) - P175 MULTICENTRIC STUDY OF SKINETHIC™ HCE TIME-TO-TOXICITY METHOD FOR SERIOUS EYE DAMAGE/EYE IRRITATION ASSESSMENT
Nathalie Alépée, L'Oreal (ABSTRACT ID: 396) - P181 IDENTIFICATION AND CHARACTERIZATION OF THYROID HORMONE DISRUPTORS IN DEVELOPING 3D NEURAL PROGENITOR CELLS IN VITRO
Jördis Klose, Leibniz Research Institute for Environmental Medicine - IUF Dusseldorf (ABSTRACT ID: 403) - P184 INVESTIGATION OF NEURODEVELOPMENTAL TOXICITY OF CHINESE HERBAL MEDICINES USING A 3D HUMAN PRIMARY NEURAL PROGENITOR CELL ASSAY IN VITRO
Jördis Klose, Leibniz Research Institute for Environmental Medicine - IUF Dusseldorf (ABSTRACT ID: 406) - P189 CYTOTOXICITY OF ZNO MICRO AND NANOPARTICLES ON HACAT AND A549 STUDIED BY MTT, NRU AND LDH VIABILITY ASSAYS
Montse Mitjans, Universitat de Barcelona (ABSTRACT ID: 416) - P200 BENZYL SALICYLATE CASE STUDY IN-SILICO SCREENING FOR ENDOCRINE DISRUPTOR POTENTIAL
Carole CHARMEAU-GENEVOIS, KREATiS (ABSTRACT ID: 433) - P201 DEVELOPMENT OF A STATISTICAL PREDICTION MODEL FOR SKIN SENSITIZATION BY COMBINING MULTIPLE IN VITRO TESTS
Yuichiro Goto, KOSÉ Corporation (ABSTRACT ID: 434) - P208 A HUMAN IPSC-BASED IN VITRO NEURONAL NETWORK FORMATION ASSAY TO INVESTIGATE NEURODEVELOPMENTAL TOXICITY OF PESTICIDES
Kristina Bartmann, IUF - Leibniz Research Institute for Environmental Medicine (ABSTRACT ID: 447) - P213 IN VITRO TESTS OF STONE WOOL FIBRES DISSOLUTION
Denis Okhrimenko, ROCKWOOL International A/S (ABSTRACT ID: 453) - P225 RETROSPECTIVE ANALYSIS OF DERMAL TRIPLE PACK DATA
David Allen, Integrated Laboratory Systems, LLC (ABSTRACT ID: 474) - P240 IN SILICO AND IN VITRO APPROACHES SUPPORTING TARGET ORGAN SAFETY ASSESSMENT IN PHARMACEUTICAL DRUG DISCOVERY
Annie Delaunois, UCB Biopharma SRL (ABSTRACT ID: 498) - P242 READ-ACROSS CAN INCREASE CONFIDENCE IN THE NEXT GENERATION RISK ASSESSMENT FOR SKIN SENSITISATION A CASE STUDY WITH RESORCINOL
Nathalie Alépée, L'Oreal (ABSTRACT ID: 500) - P243 BEYOND ANIMAL TESTING FOR SKIN SENSITIZATION OF COSMETIC INGREDIENTS A CASE STUDY WITH PROPYL PARABEN
Nathalie Alépée, L'Oreal (ABSTRACT ID: 502) - P245 BISPHENOL A, BISPHENOL F AND BISPHENOL S THE BAD AND THE UGLY. WHERE IS THE GOOD?
Sophie Fouyet, UMR CNRS 8038, Laboratoire de Chimie-Toxicologie Analytique et Cellulaire, Faculté de Pharmacie de Paris, Université de Paris, 75006 Paris, France (ABSTRACT ID: 509) - P262 TOWARDS THE DEVELOPMENT OF ANIMAL PRODUCT-FREE IN VITRO SYSTEMS FOR NGRA OF CONSUMER GOODS
Sarah Hatherell, Unilever (ABSTRACT ID: 538) - P274 APPLICATION OF HUMAN INDUCED PLURIPOTENT STEM CELL CARDIOMYOCYTES (HIPSC-CM) IN PRECLINICAL IN VITRO CARDIOTOXICITY ASSESSMENT CHALLENGES AND OPPORTUNITIES
Vitalina Gryshkova , UCB Biopharma (ABSTRACT ID: 554) - P275 DEFINING THE REPRODUCIBILITY AND APPLICABILITY DOMAIN OF DEVTOX QUICKPREDICT, A HUMAN PLURIPOTENT STEM CELL-BASED DEVELOPMENTAL TOXICITY ASSAY
Jessica Palmer, Stemina Biomarker Discovery, Inc. (ABSTRACT ID: 555) - P277 A TARGETED METABOLOMICS-BASED ASSAY USING HUMAN INDUCED PLURIPOTENT STEM CELL-DERIVED CARDIOMYOCYTES IDENTIFIES STRUCTURAL AND FUNCTIONAL CARDIOTOXICITY POTENTIAL
Jessica Palmer, Stemina Biomarker Discovery, Inc. (ABSTRACT ID: 557) - P280: THE EXTENT TO WHICH IN VITRO DISTRIBUTION KINETICS DETERMINES DIFFERENCES IN INTRINSIC HEPATIC CLEARANCE BETWEEN ASSAY SETUPS
Susana Proença, (ABSTRACT ID: 560) - P281 INTEGRATED STRATEGY FOR EYE IRRITATION ASSESSMENT OF AGROCHEMICAL FORMULATIONS
María Laura Gutiérrez, CONICET - UBA (ABSTRACT ID: 563) - P283 CRISPR-CAS9 GENE EDITING IN CULTURED FISH CELLS – TOWARD A NEW ERA OF MECHANISTIC TOXICOLOGY
Marina Zoppo, Eawag (ABSTRACT ID: 565) - P284 APPLICATION OF IN SILICO TOOLS DEVELOPED WITHIN LIFE-VERMEER FOOD CONTACT MATERIALS AS CASE STUDY
Birgit Mertens, Sciensano (ABSTRACT ID: 566) - P285 IDENTIFYING PUTATIVE MODE-OF-ACTIONS FOR ENVIRONMENTAL CHEMICALS USING HIGH-THROUGHPUT PHENOTYPIC PROFILING
Johanna Nyffeler, ORISE grantee at US Environmental Protection Agency (ABSTRACT ID: 567) - P288 INTERNATIONAL APPROACHES TO IMPLEMENTING ALTERNATIVE TEST METHODS FOR MARINE BIOTOXINS IN SHELLFISH
Katherine Groff , PETA Science Consortium International e.V. (ABSTRACT ID: 571) - P290 THE CHANGING FACE OF CHEMICALS LEGISLATION IN INDIA OPPORTUNITIES TO MINIMISE TESTING ON ANIMALS
Ankita Pandey, People for the Ethical Treatment of Animals (PETA) India (ABSTRACT ID: 574) - P310 EVALUATION OF ANTI-EGFR INDUCED ON- AND TARGET-MEDIATED ADVERSE EFFECTS IN A MICROFLUIDIC 3D HUMAN CO-CULTURE MODEL
Juliane Hübner, Technische Universität Berlin (ABSTRACT ID: 615) - P313 ENDOCRINE DISRUPTORS – HARMONISING WITH JUST 1R (REPLACEMENT) IN MIND
Emma Grange, Cruelty Free International (ABSTRACT ID: 621) - P316 KEEP IT SIMPLE, SAVE YOUR MONEY AND STICK TO THE PRECLINICAL IN VITRO TOOLS FOR PULMONARY DRUG DEVELOPMENT
Marius Hittinger, PharmBioTec GmbH (ABSTRACT ID: 626) - P342 CHARACTERIZATION OF CHEMICAL SUBSTANCES USING CYTOCHROME P450 INHIBITION DATA
Kouichi Yoshinari, University of Shizuoka (ABSTRACT ID: 674) - P378 GUIDANCE ON DOSE-SETTING IN REPEATED-DOSE TOXICITY STUDIES; OUTCOME OF AN ECETOC TASK FORCE
Marco Corvaro, Corteva Agriscience (ABSTRACT ID: 747) - P386 DEVELOPMENT OF AN “AGITATED” IN-VITRO TEST FOR GLASS FIBRE DISSOLUTION
Elodie Chaudan, Saint-Gobain Research Paris (ABSTRACT ID: 757) - P387 USING A BONE MARROW MICROPHYSIOLOGICAL SYSTEM TO INFORM ONCOLOGY DRUG-COMBINATION SCHEDULING
Benedicte Recolin, AstraZeneca (ABSTRACT ID: 758) - P393 TARGETTRI SAFETY ASSESSMENT AND DE-RISKING OF NOVEL DRUG TARGETS
Simon Folkertsma, TNO (ABSTRACT ID: 772) - P397 MACHINE LEARNING BASED META-ANALYSIS USING MULTIPLE TOXICOGENOMICS DATASETS DOES NOT IMPROVE GENOTOXICITY PREDICTION
Danyel Jennen, Department of Toxicogenomics, Maastricht University (ABSTRACT ID: 776) - P405 HUMAN IPSC-DERIVED PROXIMAL TUBULAR CELLS-BASED TRANSCRIPTOMICS DATA TO EVALUATE CADMIUM EXPOSURE AT A HIGH TEMPORAL RESOLUTION
Pranika Singh, Edelweiss Connect GmbH and University of Basel (ABSTRACT ID: 791) - P413 IN VITRO CELL TRANSFORMATION BIOMARKERS AS CRITERIA FOR EVALUATING POTENTIAL CARCINOGENS
Maryna Anisovich, Republican unitary enterprise «Scientific practical centre of hygiene» (ABSTRACT ID: 801) - P415 TRICHLOROETHYLENE GLUTATHIONE CONJUGATES BIOTRANSFORMATION KINETICS AND IMPACT ON OXYGEN CONSUMPTION RATES (OCR) IN HUMAN RENAL PROXIMAL TUBULAR CELLS (RPTEC/TERT1)
Liliana Capinha, Vrije Universiteit Amsterdam (ABSTRACT ID: 803) - P438 COSMETIC EUROPE’S LONG RANGE SCIENCE STRATEGY NON-ANIMAL SAFETY ASSESSMENT CASE STUDY OF PHENOXYETHANOL IN COSMETICS
MATTHEW DENT, Unilever Safety and Environmental Assurance Centre (ABSTRACT ID: 874) - P439 THE RTGILL-W1 CELL LINE ASSAY TO PREDICT FISH ACUTE TOXICITY OF WATER SAMPLES AND CHEMICALS (ISO 211152019)
Melanie Fischer, Eawag (ABSTRACT ID: 875) - P441 HPLACENTOX NEW METHOD FOR ENDOCRINE DISRUPTORS ASSESSMENT USING A HUMAN PLACENTAL MODEL
Elodie OLIVIER, Université de Paris (ABSTRACT ID: 878) - P451 TOWARDS AN ADME COMPETENT 4-ORGAN-CHIP
Beren Atac Wagegg, TissUse GmbH (ABSTRACT ID: 923) - P471 QUANTITATIVE SENSITIZING POTENCY ASSESSMENT USING GARDSKIN DOSE-RESPONSE
Henrik Johansson, SenzaGen AB (ABSTRACT ID: 961) - P475 HUMAN-RELEVANT APPROACHES TO ASSESS EYE CORROSION/IRRITATION POTENTIAL OF AGROCHEMICAL FORMULATIONS
Amy Clippinger, PETA Science Consortium International (ABSTRACT ID: 965) - P476 ASSESSMENT OF SKIN SENSITIZATION POTENTIAL OF FRAGRANCE INGREDIENTS USING THE U-SENS™ ASSAY
Isabelle Lee, Research Institute For Fragrance Materials RIFM (ABSTRACT ID: 966) - P486 BUILDING CONFIDENCE IN USING NEW APPROACH METHODOLOGIES FOR CONSUMER-BASED RISK ASSESSMENT CHALLENGES AND FUTURE PERSPECTIVES
Alistair Middleton, Unilever (ABSTRACT ID: 978) - P488 GARD™SKIN AND GARD™POTENCY A PROOF OF CONCEPT STUDY TO INVESTIGATE THE APPLICABILITY DOMAIN FOR AGROCHEMICAL FORMULATIONS.
Marco Corvaro, Corteva Agriscience (ABSTRACT ID: 980) - P492 A STUDY ON THE CORRELATION BETWEEN THE HET-CAM AND THE RECONSTRUCTED VAGINAL TISSUE MODEL FOR SAFETY TEST OF FEMININE WASH
Minseok Choi, AMOREPACIFIC (ABSTRACT ID: 986) - P493 IDENTIFICATION OF SKIN SENSITIZING IMPURITIES IN REACTION MIXTURES BY FLUORESCENT NITROBENZOXADIAZOLE-LABELED GLUTATHIONE
Gaku Yamamoto, Sumitomo Chemical Co., Ltd. (ABSTRACT ID: 987) - P495 ASSESSING EXPERIMENTAL UNCERTAINTY IN DEFINED APPROACHES FOR SKIN SENSITZATION
Susanne Kolle, BASF SE (ABSTRACT ID: 989) - P496 CYTOTOXICITY EVALUATION OF TETRABROMOBISPHENOL A AND POLYSTYRENE NANOPLASTICS ON RTGILL-W1 FISH CELLS
Inés Tejeda, Biology Department (Cell Biology), Faculty of Sciences, Universidad Autónoma de Madrid, Madrid, Spain (ABSTRACT ID: 990) - P502 QUALITY CONTROL OF HEPATIC STEM CELLS DERIVED FROM HUMAN FETAL HEPATOCYTES USING NOVEL NANOPARTICLES
Riko Jinno, Sojo University (ABSTRACT ID: 997) - P504 U-SENS™ APC CAN BE USED AS AN ALTERNATIVE IN CASE OF STRONG CHEMICAL-INDUCED AUTOFLUORESCENCE AT THE FITC-SPECIFIC WAVELENGTHS
Nathalie Alépée, L'Oreal (ABSTRACT ID: 999) - P505 DEVELOPING A DEFINED APPROACH FOR EYE IRRITATION TESTING
Neepa Choksi, Integrated Laboratory Systems, LLC (ABSTRACT ID: 1001) - P507 THYROID DISRUPTION RESCUE OF IODIDE ON A ZEBRAFISH VERTEBRATE MODEL
María José Mazón, Biobide (ABSTRACT ID: 1003) - P509 VARIABILITY IN THE RABBIT SKIN IRRITATION ASSAY
John Rooney, Integrated Laboratory Systems, LLC (ABSTRACT ID: 1005) - P510 DEVELOPMENT OF AN IN SILICO PLATFORM TO ASSESS DEVELOPMENTAL AND REPRODUCTIVE TOXICITY (DART)
Monique van der Voet, Vivaltes (ABSTRACT ID: 1006) - P511 APPLICATION OF DEFINED APPROACHES FOR SKIN SENSITIZATION TO AGROCHEMICAL PRODUCTS
Judy Strickland, Integrated Laboratory Systems, LLC (ABSTRACT ID: 1007) - P512 TOXICITY OF THE AEROSOL INGREDIENT ALUMINIUM CHLOROHYDRATE (ACH) IN AN IN VITRO MODEL OF HUMAN ALVEOLAR CELLS
Daniela Leme, Federal University of Paraná (UFPR) (ABSTRACT ID: 1009) - P514 INTEGRATED APPROACH TO EVALUATE SKIN PERMEATION AND SKIN SENSITIZATION OF BACCHARIS TRIMERA (LESS.) DC ASTERACEAE
Gabriella Lisboa dos Santos, Federal University of São Paulo (ABSTRACT ID: 1011) - P515 DOSE-DEPENDENT CITOTOXICITY OF BISMUTH NANOPARTICLES PRODUCED BY LASIS IN A REFERENCE MAMMALIAN CELL LINE BALB/C 3T3 AND HUMAN MESENCHYMAL STEM CELLS
Alessandra de Aguiar, Carlos Chagas Institute (Fiocruz/PR) (ABSTRACT ID: 1013) - P523 EVALUATION OF CELLULAR DAMAGE USING IN VITRO INTESTINAL MODELS AFTER EXPOSURE TO TETRABROMOBISPHENOL A AND POLYSTYRENE NANOPLASTICS
Patricia Soto Bielicka, Autonomous University of Madrid (ABSTRACT ID: 1024) - P538 IMPLEMENTATION OF AN IN VITRO TRANSGENIC RODENT (TGR) ASSAY FOR THE DETECTION OF POTENTIAL MUTAGENS AND ASSESSMENT OF THEIR MECHANISM OF ACTION
Barbara Birk, BASF SE (ABSTRACT ID: 1045) - P540 ASSESSING HUMAN CARCINOGENICITY RISK WITHOUT THE RODENT CANCER BIOASSAY
Amber Goetz, Syngenta Crop Protection LLC (ABSTRACT ID: 1047) - P541 WEIGHT OF EVIDENCE APPROACH FOR SKIN SENSITIZATION POTENCY CATEGORIZATION OF FRAGRANCE INGREDIENTS
Mihwa Na, Research Institute for Fragrance Materials (ABSTRACT ID: 1048) - P542 EFFECT OF MINERAL FIBRES ON ACUTE TOXICITY AND INFLAMMATION IN AN IN VITRO MODEL OF HUMAN M0-M1-M2 MACROPHAGES
Serena Mirata , Department of Earth, Environment and Life Sciences (DISTAV), University of Genova, Genova, Italy (ABSTRACT ID: 1049) - P543 AN ALTERNATIVE IN VITRO APPROACH TO EVALUATE IN HUMAN ENDOTHELIAL CELLS AND MONOCYTES BOTH DIRECT AND INDIRECT CARCINOGENIC EFFECT OF ASBESTOS FIBERS
Vanessa Almonti, University of Genoa (ABSTRACT ID: 1052) - P544 IMPEDANCE SPECTROSCOPY AS TOOL TO DETERMINE CONCENTRATION-DEPENDENT EYE IRRITATION EFFECTS
Nicola Knetzger, Fraunhofer Institut for Silicate Research (ISC) (ABSTRACT ID: 1053) - P549 A 3D ALVEOLAR IN VITRO MODEL FOR THE PREDICTION OF CHEMICAL RESPIRATORY SENSITIZERS AND IRRITANTS
Sabina Burla-Mihaescu, Luxembourg Institute of Science and Technology (ABSTRACT ID: 1058) - P552 DEVELOPING A NEW APPROACH TO ASSESS CROP PROTECTION CHEMICAL SAFETY THAT MINIMIZES RELIANCE ON VERTEBRATE TESTING AND PROTECTS HUMAN HEALTH AND THE ENVIRONMENT
Natalia Ryan, Syngenta (ABSTRACT ID: 1062) - P554 TOWARD REGULATORY ACCEPTANCE OF RECOMBINANT FACTOR C BASED ASSAYS IN THE UNITED STATES
Elizabeth Baker, Physicians Committee for Responsible Medicine (ABSTRACT ID: 1064) - P562 POLICY INITIATIVES FOR INTEGRATING NEW APPROACH METHODOLOGIES FOR TESTING PHARMACEUTICALS IN THE UNITED STATES
Elizabeth Baker, Physicians Committee for Responsible Medicine (ABSTRACT ID: 1074) - P566 DYNAMIC IN VITRO ASSESSMENT OF LUNG EPITHELIAL CELLS UNDER MECHANICAL STRAIN
Sandeep Keshavan, Adolphe Merkle Institute-Université de Fribourg (ABSTRACT ID: 1078) - P567 AN INVERTED IN VITRO TRIPLE CULTURE MODEL OF THE HEALTHY AND INFLAMED INTESTINE ADVERSE EFFECTS OF POLYETHYLENE PARTICLES
Mathias Busch, IUF - Leibniz Research Institute for Environmental Medicine (ABSTRACT ID: 1079) - P568 COMPARISON OF THE EFFECTS OF ENGINEERED NANOMATERIALS IN SIMPLE VERSUS COMPLEX IN VITRO MODELS OF HUMAN INTESTINE
Angela Kämpfer, IUF - Leibniz Research Institute for Environmental Medicine (ABSTRACT ID: 1080) - P569 GAP ANALYSIS OF EFFECT-DIRECTED MONITORING TOOLS FOR RISK ASSESSMENT OF DRINKING WATER
Valentin De Gussem, Utrecht University (ABSTRACT ID: 1081) - P572 PERFORMANCE OF THE GHS MIXTURES EQUATION FOR PREDICTING ACUTE ORAL TOXICITY
Jon Hamm, Integrated Laboratory Systems, LLC (ABSTRACT ID: 1087) - P577 HIGH-THROUGHPUT SCREENING TO PREDICT HERG INHIBITION
Shagun Krishna, NTP, NIEHS (ABSTRACT ID: 1095) - P578 SYSTEMATIC EVIDENCE MAPPING OF RESEARCH ON ENVIRONMENTAL EXPOSURES AND CARDIOVASCULAR DISEASE
Shagun Krishna, NTP, NIEHS (ABSTRACT ID: 1096) - P579 AN IN VITRO PANEL FOR COSMETIC CHEMICAL SYSTEMIC TOXICITY SAFETY TESTING
Catherine Mahony, Procter & Gamble Technical Centres Ltd, Reading, UK (ABSTRACT ID: 1097) - P581 ASSESSMENT OF PHOTOTOXIC POTENTIAL OF CHEMICALS USING THE IN VITRO 3D-PT SKINETHIC RHE TEST METHOD
Nathalie Alépée, L'Oreal (ABSTRACT ID: 1099) - P586 INTERNATIONAL REGULATORY NEEDS FOR ACUTE TOXICITY DATA
Judy Strickland, Integrated Laboratory Systems, LLC (ABSTRACT ID: 1108) - P588 RECONSTRUCTED HUMAN EPIDERMIS TO PREPARE FOR ANIMAL TEST BAN FOR COSMETICS IN COLOMBIA
Liseth Diaz, Belcorp (ABSTRACT ID: 1112)
Theme 2: Innovative technologies
- P1 LINKING LRI AMBIT CHEMOINFORMATIC SYSTEM WITH THE IUCLID6 SUBSTANCE DATABASE TO SUPPORT READ-ACROSS OF SUBSTANCE ENDPOINT DATA AND CATEGORY FORMATION
Bruno Hubesch, Cefic LRI (ABSTRACT ID: 14) - P4 AN IN VIVO SCREENING DEVICE PLATFORM TO REDUCE ANIMAL EXPERIMENTS
Lorenzo Moroni, Maastricht University (ABSTRACT ID: 36) - P11 SYSTEMATIC REVIEWS TO REPLACE SPECIFIC ANIMAL EXPERIMENTS FOR ANSWERING BIOLOGICAL QUESTIONS
Cathalijn Leenaars, ZTL-MHH (ABSTRACT ID: 83) - P14 DEVELOPMENT AND USE OF DRUG-INDUCED CHOLESTASIS, CIRRHOSIS, HEPATITIS, AND STEATOSIS PREDICTION MODELS
Hyun Kil SHhin, (ABSTRACT ID: 97) - P15 CELLASYS #8 A MICROPHYSIOMETRIC ASSAY TO ASSES ENHANCED CELL CULTURE MEDIA
Joachim Wiest, cellasys GmbH (ABSTRACT ID: 100) - P16 INSIGHTS ON P-GLYCOPROTEIN LIGAND INTERACTIONS FROM MOLECULAR DYNAMICS SIMULATIONS
Liadys Lagares, Kemijski Inštitut (ABSTRACT ID: 104) - P26 A PRECISELY ADJUSTABLE, LIVE ANIMAL FREE OCULAR CORROSION MODEL
Markus Glaudo, Aachen Centre of Technology Transfer in Ophthalmology, (ACTO e. V.), Aachen, Germany (ABSTRACT ID: 125) - P27 THE VALIDATION OF A SEMI-HIGH THROUGHPUT AUTOMATED OCULAR TOXICITY TEST
Markus Glaudo, Aachen Centre of Technology Transfer in Ophthalmology, (ACTO e. V.), Aachen, Germany (ABSTRACT ID: 126) - P31: A NEW RELIABLE IN SILICO SCREEN FOR ENDOCRINE DISRUPTORS, EFFECTIVELY REDUCING ANIMAL EXPERIMENTATION
Paul Thomas, KREATIS (ABSTRACT ID: 133) - P35 EARLY-CAREER RESEARCHERS ADVANCING 21ST CENTURY SCIENCE AN EDUCATIONAL INITIATIVE FOR HUMAN-RELEVANT BIOMEDICAL RESEARCH
Janine McCarthy, Physicians Committee for Responsible Medicine (ABSTRACT ID: 147) - P40 THREE-STAGE APPROACH FOR EVALUATION OF A CHEMICALLY DEFINED CELL CULTURE MEDIUM FOR THE CACO-2 CELL LINE SHORT-TERM EFFECTS, DIFFERENTIATION POTENTIAL AND LONG-TERM CULTIVATION
Joachim Wiest, cellasys GmbH (ABSTRACT ID: 157) - P41 EVALUATION OF A NOVEL ORAL MUCOSA IN VITRO IMPLANTATION MODEL FOR ANALYSIS OF MOLECULAR INTERACTIONS WITH DENTAL ABUTMENT SURFACES
Sue Gibbs, Amsterdam UMC & ACTA (ABSTRACT ID: 158) - P47 CHEMICALLY DEFINED FORMATION OF SPHEROIDS LOADED WITH SUPERPARAMAGNETIC IRON OXIDE NANOPARTICLES
Joachim Wiest, cellasys GmbH (ABSTRACT ID: 169) - P62 NON-ANIMAL EFFICACY TESTING APPROACHES FOR ECTOPARASITICIDES
Katherine Groff , PETA Science Consortium International e.V. (ABSTRACT ID: 194) - P63 USE OF TRANSCRIPTOMICS TO SUBSTANTIATE SIMILAR BIOLOGICAL ACTIVITY IN A READ ACROSS EXERCISE FOR SAFETY ASSESSMENT OF COSMETIC INGREDIENTS.
Jorge Naciff, Procter and Gamble (ABSTRACT ID: 197) - P72 OPTIMIZATION OF GENE SILENCING IN A CELL-LADEN 3D ORGAN-LIKE MODEL BY MEANS OF RNA INTERFERENCE
Ida Shaef, Technische Universität Berlin (ABSTRACT ID: 211) - P79 RETHINK3R - DESIGN THINKING WORKSHOPS TOWARDS THE IMPLEMENTATION OF THE 3RS
Annemarie Lang, Charité-Universitätsmedizin Berlin (ABSTRACT ID: 220) - P87 POPULATION EFFECT ON DRUG METABOLISM AND ABSORPTION USING EX VIVO INTESTINAL TISSUE EXPLANTS IN THE INTESTINE EXPLANT BARRIER CHIP
Evita van de Steeg, TNO (ABSTRACT ID: 239) - P89 KIDNEY-ON-A-CHIP – INTEGRATING GLOMERULAR FILTRATION AND TUBULAR REABSORPTION MODELS
Michelle Jäschke, TissUse GmbH (ABSTRACT ID: 241) - P93 NUTRITIONAL REQUIREMENTS OF FISH CELL LINES –DEVELOPMENTS TOWARDS A SERUM-FREE CULTURE MEDIUM
Barbara Jozef, EAWAG (ABSTRACT ID: 249) - P104 DEVELOPMENT OF A DIET-INDUCED MODEL FOR NON-ALCOHOLIC STEATOHEPATITIS (NASH) AND FIBROSIS IN A TRIPLE CELL-TYPE, SPHEROID-BASED LIVER-ON-CHIP MODEL WITH MICROFLUIDICS
Geurt Stokman, TNO Metabolic Health Research (ABSTRACT ID: 271) - P110 DEVELOPMENT OF AN IN VITRO B CELL ASSAY FOR TETANUS AND DIPHTHERIA CONTAINING VACCINE BATCH TESTING USING ANTIGEN SPECIFIC B CELLS FROM HEALTHY DONORS
Olga Ticha, Paul-Ehrlich Institute, Langen, Germany (ABSTRACT ID: 282) - P113 A DIGITAL TOOL BASED ON TRANSCRIPTOMIC DATA FOR THE INTEGRATION OF BIOLOGICAL FINGERPRINT ANALOGIES IN THE READ-ACROSS APPROACH
Romain Grall, L'Oréal R&I (ABSTRACT ID: 291) - P119 ANIMAL MODELS USED FOR REGENERATIVE MEDICINE RESEARCH IN COSTA RICA. A CASE OF STUDY SKIN WOUND HEALING.
Johan Morales-Sánchez, Costa Rica Institute of Technology (ABSTRACT ID: 304) - P122 CURRENT STATUS OF THE RE-PLACE DATABASE COMPRISING EXPERTISE ON THE USE OF NAMS IN BELGIUM
Mieke Van Mulders, Sciensano / Vrije Universiteit Brussel (ABSTRACT ID: 308) - P125 ASSESSING REPRODUCIBILITY, ROBUSTNESS AND PREDICTIVITY OF AN IN VITRO METHOD TO ASSESS DIO1 INHIBITION IN HUMAN LIVER MICROSOMES
Andreas Weber, BASF SE (ABSTRACT ID: 313) - P126 MINIATURIZING OF LIVER METABOLOMICS IN VITRO – A NEW SCREENING APPROACH TO GENERATE METABOLIC FINGERPRINT IN HEPG2 CELLS
Sabina Ramirez Hincapie, BASF SE (ABSTRACT ID: 314) - P139 DEVELOPMENT OF AN OPTIMIZED CULTURE MEDIUM TO DIFFERENTIATE MUTZ-3 CELLS INTO MUTZ-LANGERHANS CELLS FOR IN VITRO SKIN SENSITIZATION ASSAYS
Patricia Böttcher, Henkel AG & Co. KGaA (ABSTRACT ID: 333) - P145 LONG TERM CULTURE FOR REPEATED DOSE ASSAY ARE 3D MODELS RELEVANT ?
Christelle Videau, EPISKIN (ABSTRACT ID: 345) - P152 A MICROFLUIDIC THYROID-LIVER PLATFORM TO INVESTIGATE MECHANISMS OF THYROID TOXICITY IN HUMANS AND RATS
Marian Raschke, Bayer AG, Pharmaceuticals Division (ABSTRACT ID: 362) - P170 PRIMARY HUMAN 3D AIRWAY-MACROPHAGE CULTURE PLATFORM TO ASSESS TOXICITY OF SUSPENDED VS AEROSOLIZED ZNO NANOPARTICLES
Samuel Constant, (ABSTRACT ID: 391) - P171 CILIOPATHIC AND INFLAMMATORY EFFECT OF POLY(IC) ON IN VITRO 3D HUMAN AIRWAY EPITHELIUM
Samuel Constant, (ABSTRACT ID: 392) - P176 CHEMICALLY DEFINED CELL CULTURE MEDIA – A CONTRIBUTION TO ADDRESS THE REPRODUCIBILITY CRISIS IN BIOMEDICAL SCIENCES
Joachim Wiest, cellasys GmbH (ABSTRACT ID: 397) - P177 REAL LIFE APPLICATION OF PROPOSED GUIDELINES FOR HIPSC BANKING IN AN ACADEMIC ENVIRONMENT
Julia Tigges, IUF - Leibniz Research Institute for Environmental Medicine (ABSTRACT ID: 398) - P179 THE HUMAN INDUCED PLURIPOTENT STEM CELL (HIPSC) TEST AS AN ALTERNATIVE METHOD FOR DEVELOPMENTAL TOXICITY TESTING
Saskia Galanjuk, IUF-Leibniz Research Institute for Environmental Medicine (ABSTRACT ID: 401) - P180 OPTIMIZING THE GENERATION OF HUMAN INDUCED NEURAL PROGENITOR CELL (HINPC)-DERIVED FUNCTIONAL NEURONAL NETWORKS FOR USE AS ALTERNATIVE MODELS IN NEUROTOXICITY TESTING
Julia Hartmann, Leibniz Research Institute for Environmental Medicine (ABSTRACT ID: 402) - P185 MATURATION OF HUMAN INDUCED PLURIPOTENT STEM CELL-DERIVED CARDIOMYOCYTES BY MECHANICAL STIMULUS
Su-Jin Lee, Korea Institute of Toxicology (ABSTRACT ID: 410) - P190 SELF-ORGANIZED PIGMENTED AND VASCULARIZED FULL SKIN TISSUE MODEL FOR MELANOMA RESEARCH
Alexandra P. Marques, 3B’s Research Group - University of Minho (ABSTRACT ID: 418) - P191 DIFFERENTIATION OF MOTOR NEURONS FOR IN VITRO POTENCY ESTIMATION OF BOTULINUM NEUROTOXINS
Maren Schenke, Research Group Food Toxicology and Replacement/Complementary Methods to Animal Testing, University of Veterinary Medicine, Foundation (ABSTRACT ID: 419) - P210 THE CARDIAC EMBRYONIC STEM CELL TEST SHOWS PRESENCE OF BIOMARKERS FOR ENDODERMAL, ECTODERMAL, AND NEURAL DIFFERENTIATION
Gina Mennen, RIVM (ABSTRACT ID: 450) - P220 ALTERNATIVE METHOD TO CULTURE INTESTINAL ORGANOIDS WITHOUT LOSS OF BIOLOGICAL FUNCTIONALITY
Kitty van Summeren, University of Applied Sciences Utrecht (ABSTRACT ID: 468) - P227 MASS SPECTROMETRY-BASED QUANTIFICATION OF ALL ANTIGENS IN DIPHTHERIA-TETANUS-ACELLULAR PERTUSSIS COMBINATION VACCINES CONTAINING ALUMINUM HYDROXIDE AS ADJUVANT
Larissa van der Maas, Intravacc (ABSTRACT ID: 476) - P228 COMBINATORIAL MODEL ORGANISM STRATEGY TO PREDICT DEVELOPMENTAL AND REPRODUCTIVE TOXICITY (DART)
Johanna Louter - van de Haar, University of Applied Sciences Utrecht (ABSTRACT ID: 477) - P229 ULTRASTRUCTURAL AND FUNCTIONAL CHARACTERIZATION OF A RECONSTRUCTED HUMAN CORNEAL EPITHELIUM (HCE) AS AN ALTERNATIVE TO ANIMAL USE
Christian Pellevoisin, EPISKIN (ABSTRACT ID: 478) - P230 MIXTURE-BASED QSAR MODELS OF OCULAR TOXICITY FOR REGULATORY HAZARD CATEGORIES
Alexander Sedykh, Sciome, LLC (ABSTRACT ID: 479) - P233 WHOLE BLOOD THROMBIN GENERATION TEST TO REDUCE ANIMALS USED FOR PLASMA COLLECTION AND SINGLE DOSE STUDIES
Maria Kiersgaard, Novo Nordisk A/S (ABSTRACT ID: 483) - P239 FULLY HUMAN SKIN-ON-A-CHIP WITH A MODULAR ARCHITECTURE AND INTEGRATED SENSORS FOR DRUG SCREENING AND DISEASE MODELLING
Patricia Zoio, ITQB - NOVA (ABSTRACT ID: 497) - P246 CHEMICALLY-SELECTIVE AND LABEL-FREE CHARCATERISATION OF PANCREAS ORGANOIDS INSIDE HYDROGEL MATRICES
Nathalie Jung, Goethe-University Frankfurt (ABSTRACT ID: 511) - P253 EVALUATION OF A HUMAN IPSC-DERIVED BBB MODEL FOR REPEATED DOSE TOXICITY TESTING WITH CYCLOSPORINE A AS MODEL COMPOUND
Sara WELLENS, University of Artois (ABSTRACT ID: 523) - P257 MICROFLUIDIC PLATFORM FOR DEVELOPMENT OF BIO-ARTIFICIAL RETINA
Devashree Jahagirdar, Institute of Chemical Technology (ABSTRACT ID: 529) - P269 A NOVEL SYSTEM OF INFUSION TO PROVIDE DRUGS WITHIN EX VIVO SKIN MODELS
Michael Pastore, Genoskin (ABSTRACT ID: 547) - P273 NEW METHODOLOGY IMPLEMENTATION FOR IN VITRO MICRONUCLEUS ANALYSIS IN A CRO (BIOAGRI LABORATÓRIO LTDA - MERIEUX NUTRISCIENCES) COMPARISON OF CONVENTIONAL MICROSCOPY AND FLOW CYTOMETRY
Juliana Falcato Vecina, Merieux Nutrisciences (Bioagri Laboratórios Ltda) (ABSTRACT ID: 553) - P286 EVALUATION OF SKIN BARRIER PROPERTIES OF COSMETIC INGREDIENTS USING RECONSTRUCTED HUMAN EPIDERMAL MODEL
Seolyeong Kim, Biosolution co. Ltd,. (ABSTRACT ID: 568) - P289 A FULL THICKNESS LONG TERM SKIN EQUIVALENT ALLOWS REPEATED TESTING OF COSMETICS TO EVALUATE EFFICACY AND SAFETY
Md Zobaer Hasan, Rohto Pharmaceutical CO.,ltd (ABSTRACT ID: 572) - P294 INVESTIGATING THE EPITHELIAL BARRIER IN HUMAN SKIN 3D TISSUE MODELS WITH A NON-INVASIVE FLUORESCEIN LEAKAGE ASSAY
Eve Gerecke, - (ABSTRACT ID: 583) - P295 NEW INSIGHT INTO THE MECHANISMS UNDERLYING 5-FLUOROURACIL-INDUCED INTESTINAL TOXICITY BY ESTABLISHING TRANSCRIPTOMIC RESPONSES IN EXPOSED HUMAN INTESTINAL ORGANOIDS
Daniela Rodrigues, FHML - Maastricht University (ABSTRACT ID: 584) - P301 AVATARS OF ANIMALS AND HUMANS 3D INTERACTIVE HOLOGRAPHIC MODELS.
Bo van Leeuwen, Utrecht University (ABSTRACT ID: 597) - P306 ENGINEERING 3D VASCULARIZED HEART TISSUES USING HPSC DERIVED CARDIAC CELLS
José Manuel Rivera Arbeláez, University of Twente (ABSTRACT ID: 609) - P308 A NOVEL IN SILICO FRAMEWORK FOR IN VITRO MODEL OPTIMIZATION THROUGH GENERALIZED ALLOMETRIC SCALING
Ermes Botte, Research Centre "E. Piaggio" - University of Pisa (ABSTRACT ID: 612) - P312 SUITABILITY AND PERFORMANCE OF BIOOCULLAR AND EPIKUTIS IN VITRO 3D TISSUE MODELS IN CHINA
Cristi Gomez, Mary Kay Inc. (ABSTRACT ID: 617) - P315 A NOVEL HUMAN MATERIAL-BASED PLATFORM TECHNOLOGY FOR TISSUE ENGINEERING
Johannes Hackethal, THT Biomaterials (ABSTRACT ID: 625) - P318 FDA'S ALTERNATIVE METHODS WORKING GROUP (AMWG) EVALUATING MICROPHYSIOLOGICAL SYSTEMS FOR REGULATORY USE
Thomas Maruna, U.S. Food and Drug Administration (ABSTRACT ID: 631) - P325 ALTERNATIVE TOXICITY TESTING STRATEGIES TO ADVANCE THE 3RS - A CASE STUDY ON CONSERVED MOLECULAR PATHWAYS -
Diksha Bhalla, KU Leuven (ABSTRACT ID: 642) - P332 DRUGS AND MUCUS DECIPHERING THE INTERACTION MECHANISMS USING A BIOSIMILAR MUCUS MODEL
Cosmin Butnarasu, University of Turin (ABSTRACT ID: 653) - P335 BETTER THAN MATRIGEL? ALTERNATIVE CELL CULTURE COATINGS FOR INDUCED PLURIPOTENT STEM CELL CULTURE AND RENAL PODOCYTE DIFFERENTIATION
Anja Wilmes, Vrije Universiteit Amsterdam (ABSTRACT ID: 660) - P339 THE USE OF ANIMAL-DERIVED PRODUCTS IN IN VITRO METHODS FOR SKIN SENSITIZATION TESTING
Bianca Marigliani, Humane Society International (ABSTRACT ID: 666) - P353 USE OF THE FULL THICKNESS MODEL, T-SKIN™, TO INVESTIGATE THE EFFECTS OF UVA AND UVB ON SKIN AND PHOTOPROTECTIVE EFFECTS OF VITAMIN C
Damien Lelièvre, EPISKIN (ABSTRACT ID: 701) - P354 MAKE PEOPLE BETTER SCIENTISTS IN THE LAB ALTERTOX VISION.
Valentin Salamone, Altertox Academy (ABSTRACT ID: 702) - P383 IN VITRO MODELING OF GASTROINTESTINAL EXPOSURE AND RESPONSE TO ENGINEERED NANOMATERIALS
Marek Puskar, MatTek In Vitro Life Science Laboratories (ABSTRACT ID: 753) - P391 A NOVEL IN SILICO TOOL FOR DOSE ASSESSMENT IN CELL MONOLAYER NANOTOXICOLOGY
Ermes Botte, Research Centre "E. Piaggio" - University of Pisa (ABSTRACT ID: 765) - P396 SUBACUTE 28-DAY RESPIRATORY TOXICITY ASSAY USING AN IN VITRO HUMAN AIRWAY MODEL
Jan Markus, Mattek IVLSL (ABSTRACT ID: 775) - P398 TRANSCRIPTOMIC ALTERATIONS IN HUMAN IPSC DERIVED PODOCYTES EXPOSED TO DOXORUBICIN, PAMIDRONATE AND CYCLOSPORINE A.
Cormac Murphy, Vrije University Amsterdam (ABSTRACT ID: 777) - P401 EVALUATION OF THE SINGLE-CELL LEVEL IMMUNO-EFFICACY OF RECOMBINANT PROTEIN FOR AVIAN INFLUENZA SUBUNIT VACCINES WITH AN NOVEL AAT INTEGRATION PLATFORM
Jie-Long He, ASIA University (Taiwan), Department of Post-Baccalaureate Veterinary Medicine (ABSTRACT ID: 782) - P411 IN VITRO SKIN IRRITATION PROTOCOL FOR THE MEDICAL DEVICES EXTRACTS USING EPIDERM MODEL
Silvia Letasiova, MatTek In Vitro Life Science Laboratories, s.r.o. (ABSTRACT ID: 799) - P417: HIPSC FLUORESCENT PROTEIN REPORTER LINES FOR DISSECTING LINEAGE-SPECIFIC CELLULAR STRESS RESPONSE DYNAMICS USING HIGH CONTENT IMAGING
Kirsten Snijders, (ABSTRACT ID: 805) - P419 LIVER SPHEROID CO-CULTURES WITH FRESH OR CRYOPRESERVED HEPATOCYTES AND ENDOTHELIAL CELLS AS TOOL TO INVESTIGATE METABOLISM AND HEPATOTOXICITY
Anett Ullrich, PRIMACYT Cell Culture Technology GmbH (ABSTRACT ID: 811) - P420 A NOVEL POLYMER GENERATES CELL REPELLENT SURFACES AND ALLOWS 3D CELL CULTURE
Anett Ullrich, PRIMACYT GmbH (ABSTRACT ID: 814) - P421 HEPATIC NON-PARENCHYMAL CELLS ISOLATED FROM RODENT LIVERS AND CHARACTERIZED FOR THE DEVELOPMENT OF PRIMARY HEPATIC CO-CULTURES
Anett Ullrich, PRIMACYT GmbH (ABSTRACT ID: 816) - P422 IMPACT OF CULTURE CONDITIONS ON THE EXPRESSION AND FUNCTION OF BILE ACID TRANSPORTERS IN PRIMARY RAT HEPATOCYTES
Anett Ullrich, PRIMACYT GmbH (ABSTRACT ID: 818) - P425 THREE-DIMENSIONAL CULTURE IMPROVES THE MORPHOLOGY AND FUNCTION OF CARDIOMYOCYTES DERIVED FROM HUMAN PLURIPOTENT STEM CELLS
Hyang-Ae Lee, Korea Institute of Toxicology (ABSTRACT ID: 828) - Jeffrey Brown, PETA Science Consortium International e.V. (ABSTRACT ID: 839)
- P436 DIFFERENTIATION AND UPREGULATION OF SPECIALIZED EPITHELIAL CELLS IN PORCINE AND HUMAN INTESTINAL ORGANOIDS
Judith Lehmann, University of Veterinary Medicine Hannover, Foundation (ABSTRACT ID: 865) - P445 SIMULATION OF DYSTOCIA IN BOVINE AND EQUINE USING MODELS PRESERVED BY THE ELNADY TECHNIQUE
Fawzy Elnady, Virginia Maryland College of Veterinary Medicine, Virginia Tech. University (ABSTRACT ID: 863) - P465: HIGH FREQUENCY APPLICATION OF CATIONIC AGENTS CONTAINING LUBRICANT EYE DROPS CAUSE CUMULATIVE CORNEAL TOXICITY IN AN EX-VIVO (EVEIT) MODEL
R Michael Dutescu, (ABSTRACT ID: 954) - P468 PROOF-OF-PRINCIPLE FOR IMPEDANCE MEASUREMENT WITH CARBON ELECTRODES FOR IMPLEMENTATION IN A BONE-ON-A-CHIP SYSTEM
Joachim Wiest, cellasys GmbH (ABSTRACT ID: 957) - P470 NEW INSIGHTS ON ALTERNATIVES IN MEDICINAL MUSHROOM RESEARCH IN SILICO PREDICTIVE EVALUATION OF EPIGENETIC MODULATORY EVENTS AND ANTI-INFLAMMATORY POTENTIAL OF POLYPHENOLS
Humberto Morris, Center for Studies on Industrial Biotechnology (CEBI), Universidad de Oriente (ABSTRACT ID: 960) - P472 EDUCATORS’ VIEWS ON DISSECTION ALTERNATIVES AT THE ONSET OF THE COVID-19 PANDEMIC
Pamela Osenkowski, National Anti-Vivisection Society (ABSTRACT ID: 962) - P473 DEVELOPMENT AND CHARACTERIZATION OF THE SKIN SURFACE TEMPERATURE MODULATION AND CONTROL (SKIN-TEMP-MC) DEVICE
Udo Bock, Bock Project Management (ABSTRACT ID: 963) - P477 AN ORGANOTYPIC RECONSTRUCTED ORAL MUCOSA MODEL ENABLING THE STUDY OF HOST-MICROBIOME REACTIONS SHOWS MULTI-SPECIES BIOFILM PROMOTES HUMAN GINGIVA EPITHELIAL BARRIER FUNCTION
Lin Shang, Academic Centre for Dentistry Amsterdam, Amsterdam, The Netherlands (ABSTRACT ID: 967) - P480 PHARMACOKINETIC FUNCTIONS OF HUMAN INDUCED PLURIPOTENT STEM CELL-DERIVED SMALL INTESTINAL EPITHELIAL CELLS
Shinji Mima, FUJIFILM Corporation (ABSTRACT ID: 970) - P482 CYTOTOXICITY OF REFERENCE ELECTRODES IN MICROPHYSIOMETRIC SYSTEMS REVISITED
Joachim Wiest, cellasys GmbH (ABSTRACT ID: 973) - P483 THE E-MORPH ASSAY SCREENING FOR ANTI-/ESTROGENIC SUBSTANCES BASED ON QUANTITATIVE CHANGES IN CELL-CELL CONTACT ORGANIZATION OF BREAST CANCER CELLS
Sebastian Dunst, German Federal Institute for Risk Assessment (BfR), German Centre for the Protection of Laboratory Animals (Bf3R) (ABSTRACT ID: 974) - P487 AN IN-VITRO MODEL OF ALVEOLAR INFLAMMATION ON A BREATHING LUNG-ON-CHIP
Clémentine Richter, Helmholtz-Institute for Pharmaceutical Research Saarland (ABSTRACT ID: 979) - P499 NON-ANIMAL DERIVED ANTIBODIES IN RESEARCH AND DIAGNOSTICS
Esther Wenzel, Abcalis GmbH (ABSTRACT ID: 994) - P500 GENERATION OF REPORTER-GENE MODELS BASED ON GENETICALLY ENGINEERED PROGENITOR CELLS USING CRISPR-CAS9 TECHNOLOGY
Marion Alriquet, Philip Morris Products S.A. (ABSTRACT ID: 995) - P501 RECONSTRUCTION OF HEPATIC SINUSOIDAL ZONATION BY ORGAN-ON-A-CHIP FROM MICRONIT
Seiichi Ishida, Division of Applied Life Science, Graduate School of Engineering, Sojo University (ABSTRACT ID: 996) - P503 RESPONSE TO RECOMMENDATION ON NON-ANIMAL-DERIVED ANTIBODIES
Becky Jones, EARA (ABSTRACT ID: 998) - P508 OPERA, AN OPEN-SOURCE AND OPEN-DATA SUITE OF QSAR MODELS
Kamel Mansouri, NICEATM/NIEHS (ABSTRACT ID: 1004) - P513 EFFECTIVE USER SUPPORT DOCUMENTATION FOR A TOXICOLOGICAL DATA RESOURCE ICE AS A CASE STUDY
Catherine Sprankle, Integrated Laboratory Systems, LLC (ABSTRACT ID: 1010) - P516 THE INHIBITION OF ADIPOGENESIS VIA AN IN VITRO ASSAY CAN REDUCE ANIMAL USE BY MORE PRECISELY ESTIMATING THE STARTING DOSE FOR THE ACUTE TOXIC CLASS METHOD
Alessandra de Aguiar, Carlos Chagas Institute (Fiocruz/PR) (ABSTRACT ID: 1015) - P517 DEVELOPMENT OF 3D CULTURES OF ZEBRAFISH LIVER AND EMBRYO CELL LINES BY HANGING DROP AND ORBITAL SHAKING METHODS
Daniela Morais Leme, Federal University of Paraná (UFPR) (ABSTRACT ID: 1016) - P518 PECTIN-BASED 3D PRINTED MODELS FOR NERVOUS TISSUE
Marta Merli, Politecnico di Milano (ABSTRACT ID: 1017) - P519 TRANSITIONING A549 CELLS TO FBS-FREE MEDIA PROCESS AND DETERMINING SUCCESS
Katherine Groff Werchadlo, PETA Science Consortium International e.V. (ABSTRACT ID: 1018) - P520 APPLICATION OF META-ANALYSIS TO DERIVATION OF POINTS-OF-DEPARTURE FOR SHORT-TERM INHALATION EXPOSURE LEVELS OF HAZARDOUS CHEMICALS
Eugene Demchuk, Agency for Toxic Substances and Disease Registry (ABSTRACT ID: 1019) - P524 SCALABLE PRODUCTION OF BIOENGINEERED HAIR AND FUR PRODUCTS PROTECTED WITH BIOSECURITY TAGGING FOR THERAPEUTIC APPLICATIONS IN HAIR LOSS AND THE PREVENTION OF FUR FARMING
Sundararaghavan Pattabiraman, GENEUS BIOTECH (ABSTRACT ID: 1027) - P525 TOWARDS A NOVEL ALTERNATIVE TOXICITY MODEL WITH NORMOTHERMICALLY PERFUSED EX VIVO LIVERS BASED ON WHOLE PORCINE SLAUGHTERHOUSE ORGANS
Alicia Ruppelt, LifeTec Group (ABSTRACT ID: 1028) - P526 EXPLOITING THE USE OF IPSC DERIVED RENAL PROXIMAL TUBULAR LIKE CELLS TO INVESTIGATE MEGALIN MEDIATED AMINOGLYCOSIDES TOXICITY
Vidya Chandrasekaran, Vrije Universiteit Amsterdam (ABSTRACT ID: 1029) - P535 GENE NETWORK REGULATIONS SHOW DIFFERENT SIGNATURES FOR MORPHOLINES AND PIPERIDINES IN THE ESTC
Gina Mennen, RIVM (ABSTRACT ID: 1042) - P537 ECM-BASED IN VITRO 3D-MODELS OF THE LIVER FOR HEPATOTOXICITY TESTING
Giuseppe Guagliano, Department of Chemistry, Materials, and Chemical Engineering "G. Natta", Politecnico di Milano, Milan, Italy (ABSTRACT ID: 1044) - P545 THE DEVELOPMENT OF AN EX VIVO ORGAN MODEL TO STUDY PROLONGED VIABILITY OF INDIVIDUAL ORGANS AND EVALUATE THE PERINATAL LIFE SUPPORT SYSTEM PROTOTYPE
Mattia D'Alessi, LifeTec Group (ABSTRACT ID: 1054) - P550 THE CHICKEN CHORIOALLANTOIC MEMBRANE AS A PRE-SCREENING METHOD FOR MONITORING BIOCOMPATIBILITY OF POROUS BIOPOLYMER SCAFFOLDS
Zuzana Demčišáková, University of Veterinary Medicine and Pharmacy in Kosice, Kosice, Slovak Republic (ABSTRACT ID: 1059) - P564 SYSTEMS VACCINOLOGY ENABLE TO EVALUATE VACCINE SAFETY AND QUALITY IN VITRO.
Takuo Mizukami, National Institute of Infectious Diseases (ABSTRACT ID: 1076) - P570 A NOVEL ALTERNATIVE TEST PLATFORM FOR REAL-TIME MONITORING OF TEER VALUES IN HUMAN EPITHELIAL TISSUE MODELS
gowsinth gunasingam, Adolphe Merkle Institute (ABSTRACT ID: 1082) - P573 CHRONIC CARDIAC CONTRACTILITY ASSESSMENT OF HUMAN IPSC-DERIVED CARDIOMYOCYTES IN A PRO-MATURATION ENVIRONMENT FOR PRECLINICAL CARDIAC SAFETY AND TOXICITY STUDIES
Bettina Lickiss, innoVitro GmbH (ABSTRACT ID: 1088) - P576 STANDARDIZING DEVELOPMENTAL TOXICOLOGY STUDY EXTRACTIONS USING AUTOMATED APPLICATION OF ONTOLOGIES
Caroline Foster, ICF (ABSTRACT ID: 1094) - P584 ALT4EI DETERMINATION OF EYE IRRITATING POTENTIAL OF 59 CHEMICALS USING EPIOCULAR™ TIME-TO-TOXICITY NEAT AND DILUTION PROTOCOLS
Silvia Letasiova, MatTek In Vitro Life Science Laboratories, s.r.o. (ABSTRACT ID: 1104) - P587 COMPARATIVE TOXICOLOGICAL ANALYSIS OF AN IPSC DERIVED AIRWAY EPITHELIUM MODEL WITH A PRIMARY BRONCHIAL AIRWAY EPITHELIUM MODEL AT AN AIR LIQUID INTERFACE USING TEMPOSEQ
Ivo Djidrovski, Newcastle University (ABSTRACT ID: 1111)
Theme 3: Ethics, Welfare and Regulation
- P6 SUCCESSES AND CHALLENGES IN NETWORKING AND PROMOTING 3RS WITHIN ITALIAN UNIVERSITIES. THE CENTRO 3R EXPERIENCE.
Arti Ahluwalia, Interuniversity Center for the Promotion of the 3Rs in Teaching and Research (Centro 3R) (ABSTRACT ID: 56) - P8 REPEATING PAST MISTAKES THE BANALITY AND FUTILITY OF NOWADAYS CIGARETTE SMOKE-RELATED ANIMAL EXPERIMENTATION
Dilyana Filipova, Doctors Against Animal Experiments (ABSTRACT ID: 61) - P10 SYSTEMATIC REVIEWS TO REPLACE ANIMAL EXPERIMENTS FOR OPTIMISING EXPERIMENTAL DESIGN
Cathalijn Leenaars, ZTL-MHH (ABSTRACT ID: 82) - P12 PROMOTING THE REPLACEMENT OF THE 3RS PRINCIPLE SHORT COURSES
Pilar Vinardell, Universitat de Barcelona (ABSTRACT ID: 90) - P23 R-ODAF OMICS DATA ANALYSIS FRAMEWORK FOR REGULATORY APPLICATION
Florian caiment, Maastricht University (ABSTRACT ID: 120) - P34 BIOLOGICAL DATA OF NONHUMAN PRIMATE DURING THE QUARANTINE PERIODS
Young-Su Yang, Korea Institute of Toxicology (ABSTRACT ID: 146) - P38 CUSTOMIZING ANIMAL WELFARE LEGISLATION FOR ANIMALS USED IN XENOTRANSPLANTATION TRIALS AND PRODUCTION IN THE UNITED STATES
Mimi Lam, University of Edinburgh (ABSTRACT ID: 152) - P42 NOVEL HOME CAGE ACTIVITY METRICS FOR POSTOPERATIVE CARE REFINEMENT IN A MOUSE SURGICAL MODEL
Fabrizio Scorrano, Novartis International AG (ABSTRACT ID: 159) - P44 THE ROLE OF THE ANIMAL WELFARE BODY IN DEVELOPING A FUNCTIONAL AND EFFICIENT CULTURE OF CARE
Thomas Bertelsen, Novo Nordisk A/S (ABSTRACT ID: 162) - P45 REDUCTION OF CONTROLS IN PRECLINICAL CLAMP STUDIES USING A NON-LINEAR MIXED-EFFECTS MODEL
Thomas Bertelsen, Novo Nordisk A/S (ABSTRACT ID: 165) - P48 MODERNIZING BIOMEDICAL RESEARCH AND REGULATORY POLICIES TO ADVANCE HUMAN HEALTH
Emily Trunnell, People for the Ethical Treatment of Animals (ABSTRACT ID: 172) - P53 3RS SELF-ASSESSMENT TOOLS TO SUPPORT RESEARCH GROUPS AND INSTITUTIONS TO TRACK, EVALUATE AND BENCHMARK THEIR 3RS ACTIVITIES
Jessica Eddy, NC3Rs (ABSTRACT ID: 179) - P67 ANIMAL DISSECTION IN TEACHING MINORS (UNDER 19 YEARS OF AGE) IN KOREA - CONTRADICTORY KOREAN LEGISLATION AND ENFORCEMENT RULE
Gwi-Hyang Lee, BIC Study (ABSTRACT ID: 202) - P84 IMPROVING QUALITY OF IN VITRO METHODS A GIVIMP CERTIFICATION PROGRAM
Amanda Ulrey, IIVS (ABSTRACT ID: 228) - P103 DEVELOPMENT OF GUIDANCE FOR IACUC MEMBERS IN KOREA APPLYING THE 3RS PRINCIPLES
Gwi-Hyang Lee, BIC Study (ABSTRACT ID: 270) - P112 IMPROVING ANIMAL RESEARCH ENHANCING SYSTEMATIC REVIEW METHODOLOGY
Cathalijn Leenaars, ZTL-MHH (ABSTRACT ID: 288) - P117 SMAFIRA SMART FEATURE BASED INTERACTIVE RANKING TO RETRIEVE POSSIBLE ALTERNATIVES FROM THE LITERATURE
Daniel Butzke, German Federal Institute for Risk Assessment (BfR) (ABSTRACT ID: 298) - P123 TELEMETRY AS METHOD TO ASSESS SEVERITY IN SHEEP
Eva Zentrich, Institute for Laboratory Animal Science, Medical School Hannover (ABSTRACT ID: 309) - P137 IDENTIFYING FISH - METHODS FOR TAGGING AND MARKING
Per E Ljung, The Swedish 3Rs Center (ABSTRACT ID: 329) - P138 THE PROBLEM OF PAIN IN ANIMAL EXPERIMENTATION
Katherine Roe, PETA (ABSTRACT ID: 330) - P143 THE RODENT IN THE ROOM CONSIDERING SENTIENCE IN RESEARCH PROGRAMS USING MICE AND RATS
Ingrid Taylor, People for the Ethical Treatment of Animals (ABSTRACT ID: 342) - P153 A PERFECT MATCH REDUCES ANIMAL USE.
Ronald Vlasblom, HU University of Applied Sciences (ABSTRACT ID: 364) - P160 IMPLEMENTATION OF ALTERNATIVE METHODS IN CHINA ACCORDING TO OECD GUIDANCE DOCUMENT ON GOOD IN VITRO METHOD PRACTICES AN EXAMPLE
yanfeng liu, L'OREAL (ABSTRACT ID: 376) - P165 DEFINING PHYSICOCHEMICAL EXCLUSION RULES TO IDENTIFY CHEMICALS THAT DO NOT REQUIRE CLASSIFICATION OF SERIOUS EYE DAMAGE/EYE IRRITATION A COSMETIC EUROPE ANALYSIS
Els Adriaens, Adriaens Consulting (ABSTRACT ID: 383) - P187 FOSTER AND FUND ENHANCING 3R ACTIVITIES AT CHARITÉ – UNIVERSITÄTSMEDIZIN BERLIN BY CHARITÉ 3R
Ida Retter, Charité Universitätsmedizin Berlin (ABSTRACT ID: 414) - P193 IMPLEMENTING THE PRINCIPLES OF 3R'S IN THE PROJECT APPLICATION, EVALUATION, AND AUTHORIZATION PROCESS IN THE UNIVERSITY OF DEBRECEN COMMITTEE OF ANIMAL WELFARE’S WORK
Ádám Deák, University of Debrecen (ABSTRACT ID: 423) - P195 MULTIMODAL MONITORING IN A PRECLINICAL STUDY WHEEL RUNNING BEHAVIOUR UNCOVERS IMPAIRED WELFARE DUE TO SERIAL INTRAPERITONEAL INJECTIONS
Eva Zentrich, Institute for Laboratory Animal Science, Medical School Hannover (ABSTRACT ID: 425) - P196 RECOMMENDATIONS ON GROUP HOUSING OF MALE MICE - A COMPILATION OF EXPERIENCES FROM SWEDISH LABORATORY ANIMAL FACILITIES AND SCIENTIFIC LITERATURE
Kaisa Askevik, Swedish 3Rs Center (ABSTRACT ID: 427) - P204 MARCHING TOWARDS ASIAN FEDERATION FOR ALTERNATIVES TO ANIMAL TESTING (AFAAT) THROUGH HARMONIZATION OF ASIAN 3R CENTRES AND ASSOCIATIONS FOR ALTERNATIVES
Mangala Gunatilake, Faculty of Medicine, University of Colombo, Sri Lanka (ABSTRACT ID: 438) - P216 DO WE REALLY HAVE THE SAME GENES? GENETIC DIFFERENCES BETWEEN HUMANS AND LAB MICE
Dilyana Filipova, Doctors Against Animal Experiments (ABSTRACT ID: 460) - P222 INTRODUCING BRAZILIAN STUDENTS TO LOBBYING - ENACTING LEGISLATION AGAINST COSMETIC TESTING ON ANIMALS
Antoniana Ottoni, Humane Society International (ABSTRACT ID: 470) - P232 RAT ACUTE SYSTEMIC TOXICITY TESTING EVALUATING REPRODUCIBILITY AND INHERENT VARIABILITY
Agnes Karmaus, Integrated Laboratory Systems, LLC (ABSTRACT ID: 482) - P252 GLOBAL EFFORT TO END ANIMAL TESTING FOR HEALTH CLAIMS OF FOODS AND BEVERAGES
Frances Cheng, People for the Ethical Treatment of Animals (ABSTRACT ID: 522) - P254 INTERNATIONAL HARMONIZATION OF NON-ANIMAL METHODS FOR BIOMEDICAL TRAINING
Frances Cheng, People for the Ethical Treatment of Animals (ABSTRACT ID: 526) - P255 ROADMAP TO REPLACEMENT – ADDRESSING SURPLUS ANIMAL BREEDING
Lindsay Marshall, Humane Society International (ABSTRACT ID: 527) - P263 TITLE WORLD PHARMACOPEIAS ARE READY TO ADOPT NON-ANIMAL IN-VITRO REPLACEMENT TESTS FOR DETECTION OF PYROGENS. ARE YOU?
Katrin Pauls, Lonza Bioscience (ABSTRACT ID: 539) - P267 EVALUATING DOG USE IN BIOMEDICAL RESEARCH IN ORDER TO IDENTIFY NON-ANIMAL, HUMAN-BASED REPLACEMENT OPTIONS.
Lindsay Marshall, The Humane Society of the United States (ABSTRACT ID: 545) - P268 RETROSPECTIVE EVALUATION OF THE ACUTE FISH TOXICITY TEST FOR PESTICIDE REGISTRATION
Patricia Ceger, Integrated Laboratory Systems, LLC (ABSTRACT ID: 546) - P276 ETHICAL AND SCIENTIFIC CONCERNS REGARDING THE CONTINUED USE OF EXPERIMENTALLY INDUCED BRAIN INJURIES IN PRIMATES
Katherine Roe, PETA (ABSTRACT ID: 556) - P279 3RS CENTRE IN LABORATORY ANIMAL SCIENCE IN SRI LANKA
Mangala Gunatilake, Faculty of Medicine, University of Colombo (ABSTRACT ID: 559) - P297 REFINING BEHAVIORAL MANAGEMENT PROGRAMS FOR RESEARCH PIGS
Carly O'Malley, Charles River Laboratories (ABSTRACT ID: 587) - P302 SYSTEMATIC REVIEW ON THE REPORTING OF MOUSE MODELS FOR BONE HEALING
Angelique Wolter, Charité-Universitätsmedizin Berlin (ABSTRACT ID: 600) - P304 INNOVATIVE ANIMAL-FREE TRAINING TO STEREOTAXIC NEUROSURGERY
Damien Gervasoni, Université Claude Bernard Lyon 1 - Centre de Recherche en Neurosciences de Lyon (ABSTRACT ID: 605) - P326 GET-AWAY HOUSING FOR BREEDING LABORATORY RATS IS TIME AWAY FROM PUPS BENEFICIAL FOR RAT DAM WELFARE?
Anna Ratuski, University of British Columbia (ABSTRACT ID: 643) - P336 EFFECTS OF TESTING MOMENT ON BEHAVIOUR AND COGNITION IN THE LABORATORY MOUSE
Aurelie Zaros, Uliège (ABSTRACT ID: 663) - P340 STUDENTS’ AND RESEARCHERS’ ATTITUDES TO THE 3RS AT THE KAROLINSKA INSTITUTET – THE IMPORTANCE OF EDUCATION
Elin Törnqvist, Kaerolinska Institutet (ABSTRACT ID: 671) - P344 ASSESSING THE UPTAKE OF RESEARCH DOG ADOPTION
Barry Londeree, The Humane Society of the United States (ABSTRACT ID: 676) - P345 ARE DOGS STILL NEEDED IN SAFETY TESTING OF PESTICIDES?
Patricia Bishop, The Humane Society of the United States (ABSTRACT ID: 681) - P364 VIRTUAL CLASS ON ALTERNATIVE METHODS IN TOXICOLOGY
Francesca Caloni, Department of Environmental Science and Policy, Università degli Studi di Milano, Milan, Italy (ABSTRACT ID: 724) - P373 NEARLY 200 MILLION ANIMALS USED IN MEDICAL RESEARCH WORLDWIDE
Katy Taylor, Cruelty Free International (ABSTRACT ID: 739) - P374 THE PREVALENCE OF GAVAGE INCIDENTS IN REGULATORY TOXICITY STUDIES
Katy Taylor, Cruelty Free International (ABSTRACT ID: 740) - P375 COMPLETING THE REPLACEMENT PROCESS, WHY DO SOME ANIMAL TESTS PERSIST?
Katy Taylor, Cruelty Free International (ABSTRACT ID: 741) - P377 THE MONOCYTE ACTIVATION TEST AS ALTERNATIVE TO THE RABBIT PYROGEN TEST CHOOSING THE OPTIMAL SERUM SOURCE FOR THE ASSAY
Eelo Gitz, Sanquin Reagents (ABSTRACT ID: 744) - P388 IPAM, THE ITALIAN PLATFORM ON ALTERNATIVE METHODS
Isabella De Angelis, Istituto Superiore di Sanità (ABSTRACT ID: 762) - P407 SCORING 3RS ACTIVITIES OF EUROPEAN MEMBER STATES
Francois Busquet, Altertox (ABSTRACT ID: 794) - P409 DIFFICULT PARADIGM SHIFT? REASONS FOR CONTINUED ANIMAL USE FOR EDUCATIONAL PURPOSES REVEALED IN NON-TECHNICAL SUMMARIES
Miriam Zemanova, Animalfree Research, Switzerland (ABSTRACT ID: 796) - P410 THE ETHICS OF NON-HUMAN PRIMATE RESEARCH
Angela Hvitved, Johns Hopkins University (ABSTRACT ID: 798) - P440 ELEARNING MODULES TO PROMOTE IMPLEMENTATION AND DEVELOPMENT OF NEW ALTERNATIVE APPROACHES TO ANIMAL TESTING CONTENT DEVELOPMENT AND POTENTIAL INTEGRATION INTO TRAINING COURSES
Amanda Ulrey, IIVS (ABSTRACT ID: 877) - P467 3R'S PRINCIPLES IN ANIMAL ETHICS AND EXPERIMENTATION HOW A METHODOLOGY TO ANALYZE MICRONUCLEUS CAN INFLUENCE THE EXCELLENCE OF LABORATORY AND REDUCE ANIMAL NUMBERS.
Juliana Falcato Vecina, Merieux Nutrisciences (Bioagri Laboratórios Ltda) (ABSTRACT ID: 956) - P479 THERE IS ALWAYS AN ALTERNATIVE. A THOUGHT-STARTER TO STIMULATE AND ORGANIZE DISCUSSION OF SCIENCE-POLICY NEEDS FOR A SUSTAINABLE REGULATION OF CHEMICALS.
Martin Paparella, Medical University Innsbruck (ABSTRACT ID: 969) - P481 NATIONAL SURVEY ON THE PROTOCOL REVIEW GUIDE APPLYING THE 3RS PRINCIPLES IN KOREA
Gwi-Hyang Lee, BIC Study (ABSTRACT ID: 971) - P491 DOG AS THE EXPERIMENTAL MODEL LABORATORY USES OF DOGS IN THE UNITED STATES
Sherry Ward, BioTred Solutions (ABSTRACT ID: 985) - P494 PYROGEN DETECTION IN PHARMACEUTICAL QUALITY CONTROL MOVING AWAY FROM THE RABBIT PYROGEN TEST WITH A READY-TO-USE MONOCYTIC CELL LINE
Laure Robert, Merck (ABSTRACT ID: 988) - P497 INCREASING THE AVAILABILITY AND QUALITY OF HUMAN TISSUE FOR RESEARCH
Janine McCarthy, Physicians Committee for Responsible Medicine (ABSTRACT ID: 992) - P521 A SURVEY ON THE USE OF ANIMAL-DERIVED MATERIALS AND REAGENTS IN SCIENTIFIC EXPERIMENTATION
Manuela Cassotta, Oltre la Sperimentazione Animale (OSA), 20054 Segrate, Milan, Italy (ABSTRACT ID: 1020) - P522 ADOPTING EU RESEARCH CATEGORY/SUBCATEGORY NOMENCLATURE TO CATEGORIZE RESEARCH USES OF DOGS
Sherry Ward, BioTred Solutions (ABSTRACT ID: 1021) - P527 3RS INFO HUB
Vivian Kral, Freie Universität Berlin (ABSTRACT ID: 1031) - P528 EFFECT OF GNAWING WOOD ENRICHMENT ON DISEASE INDUCTION IN A MOUSE MODEL FOR DIET-INDUCED NASH
Geurt Stokman, TNO Metabolic Health Research (ABSTRACT ID: 1033) - P529 ASSOCIATIONS BETWEEN CLINICAL SIGNS AND PATHOLOGICAL FINDINGS IN TOXICITY TESTING
Antero Silva, Karolinska Institutet (ABSTRACT ID: 1034) - P530 ACCELERATING THE UPTAKE OF NON ANIMAL METHODS IN BIOSCIENCE RESEARCH SYSTEM DYNAMICS AND INDIVIDUAL RESPONSIBILITY
Celean Camp, FRAME (ABSTRACT ID: 1036) - P531 EXTENSION OF THE PERFORMANCE STATISTICS OF DEFINED APPROACHES TO DISTINGUISH BETWEEN THE THREE UN GHS CATEGORIES FOR EYE HAZARD IDENTIFICATION AND BEYOND
Els Adriaens, Adriaens Consulting (ABSTRACT ID: 1037) - P532 IS IT POSSIBLE TO STEM THE TIDE OF GA ANIMAL USE IN BIOMEDICAL RESEARCH?
Amy Beale, FRAME (ABSTRACT ID: 1038) - P536 PERFORMANCE STATISTICS OF DEFINED APPROACHES FOR EYE HAZARD IDENTIFICATION OF LIQUIDS TO DISTINGUISH BETWEEN THE THREE UN GHS CATEGORIES
Els Adriaens, Adriaens Consulting (ABSTRACT ID: 1043) - P551 EFFECT OF COOLING AS AN ANAESTHETIC METHOD FOR ZEBRAFISH (DANIO RERIO)
DPN DE SILVA, Uva Wellassa University (ABSTRACT ID: 1061) - P563 CHALLENGES IN DEVELOPING AN ONLINE ANIMAL ETHICS COURSE
Josephine Joya, The University of New South Wales (ABSTRACT ID: 1075) - P583 LACK OF ENFORCEMENT ACTIONS BY USDA AGAINST RESEARCH FACILITIES USING ANIMALS
Mary Hilley, The Humane Society of the United States (ABSTRACT ID: 1102) - P585 COOPERATIVE TRAINING IS AN OPPORTUNITY FOR REFINEMENT THAT ELIMINATES RESTRAINT AS A SOURCE OF VARIATION AND CONFOUNDING TO IMPROVE THE PREDICTIVE VALUE OF PRIMATE MODELS
Scott Oppler Jr, University of Minnesota (ABSTRACT ID: 1106)
Theme 4: Disease
- P3 PROTECTIVE EFFECT OF MELATONIN ON HYPOXIA-INDUCED CARDIOMYOCYTE DIFFERENTIATION OF MOUSE EMBRYONIC STEM CELLS
Eui-Bae Jeung, Chungbuk National University (ABSTRACT ID: 33) - P21 MONITORING INNOVATION AND SOCIETAL IMPACT OF BIOMEDICAL RESEARCH
Janine McCarthy, Physicians Committee for Responsible Medicine (ABSTRACT ID: 117) - P24 CORNEAL EDEMA SIMULATION AND THERAPY IN THE EX VIVO EYE IRRITATION TEST (EVEIT)
Claudia Panfil, Aachen Centre of Technology Transfer in Ophthalmology, (ACTO e. V.), Aachen, Germany (ABSTRACT ID: 123) - P49 CERTAIN HARMS AND UNCERTAIN BENEFITS IN ANIMAL MODELS FOR THE STUDY OF HUMAN DEPRESSION AND ANXIETY
Emily Trunnell, People for the Ethical Treatment of Animals (ABSTRACT ID: 173) - P51 THE EVALUATION OF CHO CELL CLUSTERING ASSAY TO TEST FOR PERTUSSIS TOXIN USING AUTOMATIC WHOLE WELL IMAGE CAPTURE AND ANALYSIS
Masaki Ochiai, National Institute of Infectious Diseases (ABSTRACT ID: 176) - P55 IN VITRO ANTITUMOR ACTIVITY OF A NOVEL ORGANOSELENIUM COMPOUND VIA TRANSFERRIN-CONJUGATED PLGA NANOPARTICLES
Pilar Vinardell, Universitat de Barcelona (ABSTRACT ID: 181) - P57 IN VITRO PREDICTION OF IN VIVO PSEUDO-ALLERGENIC RESPONSE VIA MRGPRX2
Thomas Bertelsen, Novo Nordisk A/S (ABSTRACT ID: 184) - P59 3D SPHEROIDS OF CHORIORETINAL ENDOTHELIAL CELLS AS AN ALTERNATIVE-TO-ANIMAL MODEL FOR DIABETIC RETINOPATHY
Manish Gore, Institute of Chemical Technology (ABSTRACT ID: 190) - P77 SYSTEMATIC REVIEW PROTOCOL ON THE EFFECT OF FECAL MICROBIOTA TRANSPLANTATION ON BEHAVIOUR IN ANIMALS
Erin Colleen Boyle, Hannover Medical School (ABSTRACT ID: 218) - P82 SEARCH FOR CANDIDATE MIRNAS IMPLICATED IN PUTATIVE ADVERSE OUTCOME PATHWAY (AOP) RELEVANT TO ALZHEIMER’S DISEASE
Maria Tsamou, ToxGenSolutions BV (ABSTRACT ID: 225) - P108: GALLERIA MELLONELLA MODEL HOST: A POTENTIAL IN VIVO TOOL TO ASSESS ANTIBODY FUNCTIONALITY
Emiliano Chiarot, GSK (ABSTRACT ID: 278) - P109 APOPTOSIS AND AUTOPHAGY CAN BE REDUCED WITH AN INOS-INHIBITOR IN AN OXIDATIVE STRESS RETINA ORGAN CULTURE MODEL
Sven Schnichels, University Eye Hospital Tübingen (ABSTRACT ID: 280) - P127 ACTIVITIES CONTRIBUTING TO THE DELETION OF THE ANIMAL TEST FOR IRREVERSIBILITY OF TETANUS TOXOIDS
Heike Behrensdorf-Nicol, Paul-Ehrlich-Institut, Germany (ABSTRACT ID: 315) - P131 THE BINACLE (BINDING AND CLEAVAGE) ASSAY FOR MEASURING THE ACTIVITY OF BOTULINUM NEUROTOXIN IN VITRO
Heike Behrensdorf-Nicol, Paul-Ehrlich-Institut, Germany (ABSTRACT ID: 319) - P141 ONCOCHIP DEVELOPMENT OF A MICROFLUIDIC HUMAN TEST PLATFORM FOR IMMUNE-ONCOLOGY THERAPY TESTING
Anna-Catharina Krebs, TissUse GmbH, TU Berlin (ABSTRACT ID: 335) - P172 ZEBRAFISH EMBRYO MODEL FOR CHEMICAL-INDUCED CRANIOFACIAL ANOMALIES
Shujie Liu, Kao Corporation (ABSTRACT ID: 393) - P183 DEVELOPMENT AND CHARACTERIZATION OF 3D SPHEROIDS FOR PRE-CLINICAL APPLICATION
Tejal Pant, Institute of Chemical Technology, Mumbai, India (ABSTRACT ID: 405) - P215 NORMOTHERMIC MACHINE PERFUSION OF HUMAN DISEASED EX VIVO LIVERS TO STUDY HEPATIC PHARMACOKINETIC PROCESSES
Lianne Stevens, TNO & LUMC (ABSTRACT ID: 457) - P234 DEVELOPMENT OF AN INTESTINAL ORGANOID-BASED PLATFORM FOR SCREENING ANTIVIRAL AGENTS
Fatma Masmoudi, Charles River (ABSTRACT ID: 485) - P237: RABIES 2+1 SEQUENTIAL TESTING TO REDUCE 40% OF THE USE OF ANIMALS
Roman Adamczyck, (ABSTRACT ID: 489) - P238: TBE SINGLE-DILUTION AS VIRAL VACCINE POTENCY TESTING TO REDUCE 70% OF THE USE OF ANIMALS
Roman Adamczyk, GSK (ABSTRACT ID: 491) - P247 HUMAN IN VITRO MODELS TO STUDY BONE METASTASES
Marjolein van Driel, Erasmus MC (ABSTRACT ID: 515) - P265 CONFIRMATORY PRECLINICAL STUDIES AS MEANS TO GUIDE DECISIONS TO ENGAGE IN CLINICAL TRIALS THE DECIDE PROJECT
Natascha Drude, Charité Universitätsmedizin Berlin -Berlin Institute of Health QUEST Center for transforming biomedical research (ABSTRACT ID: 541) - P292 DEVELOPMENT OF AN EX-VIVO RETINAL DYSTROPHY MODEL BY LIGHT INDUCED NEURODEGENERATION
Jose Hurst, University Eye Hospital Tuebingen (ABSTRACT ID: 577) - P305 COMPARING HUMAN CELL LINE CO-CULTURES AND PORCINE ORGANOIDS STUDYING (PATHO)PHYSIOLOGICAL INTESTINAL MECHANISMS
Pascal Hoffmann, University of Veterinary Medicine Hannover (ABSTRACT ID: 606) - P314 TRANSEPITHELIAL ELECTRICAL RESISTANCE AS A FAST READ-OUT OF IN VITRO AND EX VIVO MODELS MIMICKING THE GI-TRACT INFLAMMATION
Sabrina Schnur, Saarland University (ABSTRACT ID: 623) - P328 ZEBRAFISH EMBRYO MODEL FOR CHEMICAL-INDUCED CLEFT PALATE.
Junichi Tasaki, Kao Corporation (ABSTRACT ID: 646) - P379 DEVELOPMENT OF FUNCTIONAL 3D CARDIOVASCULAR CONSTRUCT
Hanna Vuorenpää, Tampere University, Finland (ABSTRACT ID: 749) - P432: REVIEW OF ANIMAL TESTING REQUIREMENTS IN WHO GUIDELINES AND RECOMMENDATIONS FOR BIOLOGICS: A PROPOSAL TO IMPLEMENT 3RS PRINCIPLES
Elliot Lilley, NC3Rs – National Centre for the Replacement, Refinement and Reduction of Animals in Research (ABSTRACT ID: 841) - P433 THE IMPORTANCE OF SIMULATED LUNG FLUID COMPOSITION FOR IN VITRO SOLUBILITY OF MINERAL WOOL FIBERS
Natasa Drnovsek, Knauf Insulation (ABSTRACT ID: 843) - P452 A NOVEL EPIDERMIS EQUIVALENT FOR IN VITRO SKIN IRRITATION TESTING CHARACTERIZATION AND PERFORMANCE
Daniela Leme, Federal University of Paraná (UFPR) (ABSTRACT ID: 924) - P462 AN INNOVATIVE MILLIFLUIDIC 3D HUMAN TRABECULAR CELL IN VITRO PLATFORM AS TOOL TO MIMIC THE PRESSURE VARIATIONS OBSERVED IN OPEN ANGLE GLAUCOMA
Anna Maria Bassi, University of Genoa, Italy (ABSTRACT ID: 941) - P474 ASSESSMENT OF COOLING EFFECTS OF TOPICAL PRODUCTS ON HUMAN SKIN IN VITRO
Udo Bock, Bock Project Management (ABSTRACT ID: 964) - P498 IMMUNOGENICITY STUDIES OF PRE- AND POST-EXPOSURE ANTI-RABIES VACCINATION (ARV) USING BALB/C MICE A SYSTEMATIC REVIEW
Hasanthi Rathnadiwakara, Department of Physiology, Faculty of Medicine, University of Colombo, Sri Lanka (ABSTRACT ID: 993) - P533: PRECISION-CUT LUNG SLICES AND REFINED CLINICAL READOUTS IN HAMSTER MODEL SUPPORT THE 3RS IN CORONAVIRUS RESEARCH
Nadia Oreshkova, WUR (ABSTRACT ID: 1040) - P548 MODULATION OF P2X7 RECEPTOR USING QUERCETIN ROLE IN COVID-19 INFLAMMATION MANAGEMENT?
Elodie OLIVIER, Université de Paris (ABSTRACT ID: 1057) - P575 CONTACTLESS BODY TEMPERATURE ASSESSMENT FOR DETERMINING HUMANE ENDPOINTS IN THE CECAL LIGATION AND PUNCTURE MODEL OF SEPSIS
Catarina Miranda, i3S - Institute for Research & Innovation in Health, Universidade do Porto (ABSTRACT ID: 1092)